NIVOLUMAB + RELATLIMAB

Source Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
Code & Prescriber Name, manner of administration Max amount No. of repeats DPMA Max Safety Net General Patient Charge
14678MMP NIVOLUMAB + RELATLIMAB
Injection (PI, CMI)
Available brands
Opdualag
(nivolumab 240 mg/20 mL + relatlimab 80 mg/20 mL injection, 20 mL vial)
480 mg 8 $18285.93 $31.60 $31.60
space


  • Legend
  • MPMedical Practitioner